Equities

TRxADE Health Inc

MEDS:NAQ

TRxADE Health Inc

Actions
Health CareHealth Care Providers
  • Price (USD)12.50
  • Today's Change0.36 / 2.97%
  • Shares traded23.69k
  • 1 Year change+42.21%
  • Beta2.2433
Data delayed at least 15 minutes, as of Jul 23 2024 18:59 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

TRxADE Health, Inc. provides a technology-enabled health services platform. The Company is focused on digitalizing the retail pharmacy and health services experience by optimizing drug procurement, the prescription journey, access to physicians in the patient’s home and patient engagement in the United States. The Company’s segments include Trxade, Inc., Integra Pharma Solutions, LLC (IPS) and Superlatus. Trxade, Inc. segment provides a web-based pharmaceutical marketplace platform-business to business (B2B) sales. IPS is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products to customers. The Superlatus segment holds Sapientia’s intellectual property for advanced food extrusion technology and The Urgent Company, which is a manufacturer of ice cream that is animal product-free, vegan, lactose-free, and made with plant-B2B sales. Its subsidiaries include Community Specialty Pharmacy, LLC, Alliance Pharma Solutions, LLC, Bonum Health, LLC and others.

  • Revenue in USD (TTM)7.78m
  • Net income in USD-19.22m
  • Incorporated2005
  • Employees8.00
  • Location
    TRxADE Health Inc2420 Brunello TraceLUTZ 33558United StatesUSA
  • Phone+1 (813) 601-3533
  • Fax+1 (800) 253-5177
  • Websitehttps://www.trxadehealth.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
brooqLy Inc30.00-309.12k15.22m0.00------507,300.00-0.0128-0.01280.00-0.0040.0002-------152.51-----------1,030,400.00-----6.923.57---98.99---11.93------
Next Technology Holding Inc2.63m20.92m15.23m8.00--0.22130.72775.78-22.23-38.742.0326.210.0452--0.6788329,163.8035.90--38.63--54.50--794.54------0.00------53.29------
Mobivity Holdings Corp6.70m-11.84m15.70m37.00------2.34-0.1759-0.17590.0996-0.17381.95--8.43181,003.30-344.97-159.74----24.9344.68-176.80-91.58---8.91-----7.38-9.60-19.91---65.90--
Focus Universal Inc1.04m-4.92m16.37m43.00--6.81--15.81-0.0756-0.07560.01590.03710.16624.0013.9424,075.81-78.98-42.74-103.50-46.893.6913.66-475.19-310.700.121-81.580.3963--197.5527.844.24---66.09--
HeartCore Enterprises Inc18.16m-7.41m16.69m99.00--4.24--0.9191-0.3553-0.35530.8710.18880.7727--6.64183,418.30-34.73---65.40--24.60---44.95-----7.340.2649--147.73--37.25------
QuoteMedia Inc18.84m220.12k16.92m131.00107.47--5.700.89820.00170.00170.1660.02322.65--17.66143,793.003.103.466.937.8250.7148.341.171.23--18.100.22590.007.8711.19-18.65-6.2025.16--
Vroom Inc712.35m-335.17m17.01m1.68k--0.2745--0.0239-190.99-203.77405.0234.240.4957--58.83425,283.60-23.33-21.29-36.91-30.2917.478.61-47.05-17.89---9.390.9454---54.170.86819.11--48.33--
Trxade Health Inc7.78m-19.22m17.07m8.00--1.25--2.19-19.980.84178.949.680.748879.8321.76972,362.50-185.02-75.29-251.66-110.2932.4644.25-247.09-45.804.75-10.200.00---19.3016.64-598.01------
Cyberloq Technologies Inc30.00k-1.41m18.19m2.00--204.48--606.29-0.0114-0.01140.00030.00070.0314----15,000.00-147.16-215.05-1,017.32-779.58-----4,690.87-3,964.08---0.4960.9241--498.888.94-4.85------
Glimpse Group Inc9.99m-21.67m18.33m115.00--1.21--1.84-1.47-1.470.63270.83170.3244--7.9053,684.68-70.38---83.69--66.36---216.98------0.00--85.51---378.74------
Zapata Computing Holdings Inc5.39m-46.99m18.45m52.00------3.42-1.61-1.610.1852-0.7238------103,634.60--------19.69---871.89-----3.19----10.01---26.81------
Jingbo Technology Inc2.76m-7.76m18.60m1.00------6.73-2.20-2.200.6483-3.320.191219.064.482,763,690.00-57.24-------17.58---299.43--0.1415-301.12----------------
Data as of Jul 23 2024. Currency figures normalised to TRxADE Health Inc's reporting currency: US Dollar USD

Institutional shareholders

5.59%Per cent of shares held by top holders
HolderShares% Held
Renaissance Technologies LLCas of 31 Mar 202433.38k2.37%
The Vanguard Group, Inc.as of 31 Mar 202414.55k1.03%
Virtu Americas LLCas of 31 Mar 202410.62k0.76%
Geode Capital Management LLCas of 31 Mar 202410.20k0.73%
BlackRock Fund Advisorsas of 31 Mar 20248.22k0.58%
Tower Research Capital LLCas of 31 Mar 20241.02k0.07%
Thrivent Trust Co.as of 30 Jun 2024357.000.03%
UBS Securities LLCas of 31 Mar 2024246.000.02%
Wells Fargo Bank, NA (Private Banking)as of 31 Mar 20248.000.00%
Bank of America, NA (Private Banking)as of 31 Mar 20240.000.00%
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.